Pressure-regulated deployment for balloon-expandable TAVI is safe, effective and results in superior valve haemodynamics regardless of prosthesis size

27 August 2023 (15:15 - 16:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Afik Snir

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail

Sutureless and rapid-deployment versus conventional bioprosthetic aortic valve replacement in patients with aortic stenosis: a systematic review and meta-analysis of randomised controlled trials

Mr J. Yadee (Chiang Mai, TH)

Abstract Slides Video

Presentation thumbnail

Self-expanding or balloon-expandable transcatheter aortic valve replacement in a German comparison

Doctor V. Oettinger (Freiburg, DE)

Abstract Slides Video

Presentation thumbnail

Evidence of early bioprosthetic valve dysfunction after TAVR in aortic valve stenosis during one-year follow-up according to VARC-3

Ms J. Heermann (Duesseldorf, DE)

Abstract Slides Video

Presentation thumbnail

Valve-in-valve transcatheter aortic valve implantation for degenerative stentless versus stented surgical bioprostheses

Mr J. Steul (Dresden, DE)

Abstract Slides

Presentation thumbnail

Vascular closure after TAVI: assessing the safety and efficacy of a collagen-based device in a real-world population

Doctor M. Grine (Coimbra, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Technical aspects of TAVI and valve-in-valve procedures

The Event

Event poster

ESC Congress 2023

27 August 2023 15:15 CET

You may be interested in

Congress Session

TAVI: technical aspects in special populations

Congress Presentation

Lifetime management of aortic stenosis: which prosthesis should we use first?

Congress Session

Personalised TAVI care in severe aortic stenosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources